Pricing Log in Create free account

Longeveron Inc. (LGVN) vs NuCana PLC Sponsored ADR (NCNA)

Longeveron Inc. and NuCana PLC Sponsored ADR are both Biotechnology companies. Longeveron Inc. and NuCana PLC Sponsored ADR are of similar size ($4.8M and $4.4M). NuCana PLC Sponsored ADR has the higher net margin (0.00% vs −1,977.6%) and the higher return on invested capital (−1,130.2% vs −4,549.0%). Across the 14 metrics below, NuCana PLC Sponsored ADR leads on 9 and Longeveron Inc. on 5.

Valuation

Metric LGVN NCNA Biotechnology median
P/E n/m n/m 8.50
P/S 3.67 n/m 9.71
P/B 0.42 0.00 2.13
Price to free cash flow n/m n/m 20.82
EV/EBITDA 0.22 1.45 0.64
EV/Sales (4.16) n/m 9.21
Earnings yield (712.23%) (226,311.31%) (33.15%)
Free cash flow yield (477.81%) (170,262.15%) (25.50%)

Profitability

Metric LGVN NCNA Biotechnology median
Gross margin 69.76% 0.00% 65.16%
Operating margin (1,992.84%) 0.00% 0.00%
Net margin (1,977.59%) 0.00% 0.00%
Free cash flow margin (1,755.69%) 0.00% 0.00%
Return on equity (203.61%) (68.70%) (56.36%)
Return on assets (145.64%) (45.24%) (48.04%)
Return on invested capital (4,549.04%) (1,130.23%) 0.00%

Growth

Metric LGVN NCNA Biotechnology median
Revenue growth (TTM) (42.74%) — 6.02%
EPS growth (last fiscal year) 50.76% 98.96% 30.26%
Revenue growth, 5-year CAGR (26.60%) — 9.41%
Net income growth, 5-year CAGR 0.00% 0.00% 0.00%

Health

Metric LGVN NCNA Biotechnology median
Debt to equity 0.00 0.00 0.00
Current ratio 2.63 4.73 4.72
Net debt to EBITDA 0.20 1.23 0.96

Dividend

Metric LGVN NCNA Biotechnology median
Dividend yield — — 0.09%
Payout ratio — — —

Size

Metric LGVN NCNA Biotechnology median
Market cap 4.79m 4.40m 135.18m

Compare with another peer

Any metric, up to five companies and an Excel export Powerpack